108 related articles for article (PubMed ID: 16335504)
1. Taking biotechnology to the patient: at what cost?
Varatharajan D
Issues Med Ethics; 2003; 11(2):54-5. PubMed ID: 16335504
[No Abstract] [Full Text] [Related]
2. Biotechnology and the spirit of capitalism.
Cohen E
New Atlantis; 2006; 12():9-23. PubMed ID: 16832952
[No Abstract] [Full Text] [Related]
3. Socioeconomic and pedagogical issues in biotechnology in Africa: a sociologist's viewpoint.
Erinosho L
Afr J Med Med Sci; 2007; 36 Suppl():77-9. PubMed ID: 17703569
[No Abstract] [Full Text] [Related]
4. Ethics in public health practice.
Kutty VR
Issues Med Ethics; 2000; 8(4):111-2. PubMed ID: 16323371
[No Abstract] [Full Text] [Related]
5. Ethical issue of bone marrow transplantation for thalassemia.
Giardini C
Bone Marrow Transplant; 1995 May; 15(5):657-8. PubMed ID: 7670391
[No Abstract] [Full Text] [Related]
6. Sharing secrets.
Nat Biotechnol; 2011 Apr; 29(4):291. PubMed ID: 21478827
[No Abstract] [Full Text] [Related]
7. Coverage options for promising technologies: Medicare's 'coverage with evidence development'.
Tunis SR; Pearson SD
Health Aff (Millwood); 2006; 25(5):1218-30. PubMed ID: 16966717
[TBL] [Abstract][Full Text] [Related]
8. Year 2006 update of the Israel National List of Health Services.
Tamir O; Rabinovich M; Shani M
Isr Med Assoc J; 2006 Sep; 8(9):595-600. PubMed ID: 17058406
[TBL] [Abstract][Full Text] [Related]
9. Basic and applied research in India: present and future.
Ramasami T; Rao AV; Natesh S
Biotechnol J; 2009 Mar; 4(3):301-5. PubMed ID: 19296436
[No Abstract] [Full Text] [Related]
10. Setting limits: medical technology and the law.
Smith GP
Syd Law Rev; 2001 Sep; 23(3):283-96. PubMed ID: 15080115
[No Abstract] [Full Text] [Related]
11. Health technology assessment: regulators or payers--who will take the lead?
Jönsson B
Clin Ther; 2008 May; 30(5):960-3. PubMed ID: 18555942
[No Abstract] [Full Text] [Related]
12. Pericarditis occurring with engraftment syndrome in a thalassemic patient.
Pakakasama S; Wanitkun S; Hongeng S
Bone Marrow Transplant; 2004 Nov; 34(9):819-20. PubMed ID: 15361914
[No Abstract] [Full Text] [Related]
13. Health related biotechnology transfer in Africa: a critique from a capabilities approach.
Botbol-Baum M
Afr J Med Med Sci; 2007; 36 Suppl():49-54. PubMed ID: 17703565
[TBL] [Abstract][Full Text] [Related]
14. Update on thalassemia: clinical care and complications.
Cunningham MJ
Pediatr Clin North Am; 2008 Apr; 55(2):447-60, ix. PubMed ID: 18381095
[TBL] [Abstract][Full Text] [Related]
15. Use of the gel test to follow up chimerism in ABO mismatched bone marrow transplantation patient: a case report.
Lumkul R; Nathalang O; Arnutti P; Janyatham A; Torcharus K; Krutvecheo T; Sriphaisal T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S311-6. PubMed ID: 16858974
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic cure 6 years after bone marrow transplantation in a beta-thalassemia patient.
Berger-Achituv S; Rothschild M; Naparstek E; Wolach B
Am J Hematol; 2009 Jun; 84(6):373-5. PubMed ID: 19415725
[No Abstract] [Full Text] [Related]
17. For the records.
Loughmiller J; Klintworth G
Nat Biotechnol; 2011 Apr; 29(4):306-9. PubMed ID: 21614804
[No Abstract] [Full Text] [Related]
18. Public healthcare resource allocation and the Rule of Rescue.
Cookson R; McCabe C; Tsuchiya A
J Med Ethics; 2008 Jul; 34(7):540-4. PubMed ID: 18591290
[TBL] [Abstract][Full Text] [Related]
19. Health system and equity perspectives in health technology assessment.
Hanvoravongchai P
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
[TBL] [Abstract][Full Text] [Related]
20. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
